feed,title,long_url,short_url
Benzinga,Longeveron Announces Abstract Highlighting Data from Phase 1 Alzheimer's Disease Trial Accepted for Developing Topics Presentation at the 2021 Annual Alzheimer's Association International Conference,https://benzinga.com/general/biotech/21/06/21703634/longeveron-announces-abstract-highlighting-data-from-phase-1-alzheimers-disease-trial-accepted-fo,https://j.mp/3wSW745
Benzinga,Longeveron Announces Abstract Highlighting Data from Phase 1 Alzheimer's Disease Trial Accepted for Developing Topics Presentation at the 2021 Annual Alzheimer's Association International Conference,https://benzinga.com/general/biotech/21/06/21703633/longeveron-announces-abstract-highlighting-data-from-phase-1-alzheimers-disease-trial-accepted-fo,https://j.mp/3daFNUG
